Lilly Korea activates adverse drug reaction reporting

All employees of Lilly Korea assume in reporting adverse drug reactions (ADRs), including all reaction to new drugs, during their working hours or daily life.

The company said all employees are obligated to report any reaction to a drug that is unexpected or undesirable and results in: (i) a change in drug therapy, including a change in dosage or discontinuation of therapy, (ii) initial or p...